Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. confirmed absence of sars-cov-2 (covid-19) infection by a negative test result 2. have chronic conditions such as heart disease, liver and kidney failure 3. pregnant or currently lactating 4. immunocompromise and/or systemic disease(s) 5. on other antiviral drugs 6. history of allergy to any of the drugs to be administered in this study

1. confirmed absence of sars-cov-2 (covid-19) infection by a negative test result 2. have chronic conditions such as heart disease, liver and kidney failure 3. pregnant or currently lactating 4. immunocompromise and/or systemic disease(s) 5. on other antiviral drugs 6. history of allergy to any of the drugs to be administered in this study

Nov. 16, 2021, 6:30 p.m. usa

confirmed absence of sars-cov-2 (covid-19) infection by a negative test result have chronic conditions such as heart disease, liver and kidney failure pregnant or currently lactating immunocompromise and/or systemic disease(s) on other antiviral drugs history of allergy to any of the drugs to be administered in this study

confirmed absence of sars-cov-2 (covid-19) infection by a negative test result have chronic conditions such as heart disease, liver and kidney failure pregnant or currently lactating immunocompromise and/or systemic disease(s) on other antiviral drugs history of allergy to any of the drugs to be administered in this study

Oct. 26, 2020, 11:31 p.m. usa

1. confirmed absence of sars-cov-2 (covid-19) infection by a negative test result 2. have chronic conditions such as heart disease, liver and kidney failure 3. pregnant or currently lactating 4. immunocompromise and/or systemic disease(s) 5. on other antiviral drugs 6. history of allergy to any of the drugs to be administered in this study

1. confirmed absence of sars-cov-2 (covid-19) infection by a negative test result 2. have chronic conditions such as heart disease, liver and kidney failure 3. pregnant or currently lactating 4. immunocompromise and/or systemic disease(s) 5. on other antiviral drugs 6. history of allergy to any of the drugs to be administered in this study